Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard J Santen

Showing results (1-10 of 110) with videos related to

Pageof 11
Sort By:
Steroids|December 12, 2003
Risk of breast cancer with progestins: critical assessment of current dataRichard J Santen
The Journal of Clinical Endocrinology and Metabolism|July 11, 2002
To block estrogen's synthesis or action: that is the questionRichard J Santen
Breast Cancer Research : BCR|January 9, 2009
Assessing individual risk for breast cancer: role of oestrogens and androgensRichard J Santen
Maturitas|October 21, 2019
"Re-booting" after retirement: Novel approach using telemedicine to solve the work-force gap in diabetes managementRichard J Santen
Endokrynologia Polska|October 18, 2007
The oestrogen paradox: a hypothesisRichard J Santen
The Journal of Steroid Biochemistry and Molecular Biology|July 23, 2013
Menopausal hormone therapy and breast cancerRichard J Santen
Steroids|September 6, 2003
Inhibition of aromatase: insights from recent studiesRichard J Santen
Women'S Health (London, England)|December 17, 2008
Does menopausal hormone therapy initiate new breast cancers or promote the growth of existing ones?Richard J Santen
Menopause (New York, N.Y.)|March 22, 2017
Use of cardiovascular age for assessing risks and benefits of menopausal hormone therapyRichard J Santen
Journal of Molecular Endocrinology|October 7, 2015
Celebrating 75 years of oestradiolEvan Simpson, Richard J Santen
Pageof 11

Showing results (1-10 of 110) with videos related to

Sort By:
Pageof 11
Steroids|December 12, 2003
Risk of breast cancer with progestins: critical assessment of current dataRichard J Santen
The Journal of Clinical Endocrinology and Metabolism|July 11, 2002
To block estrogen's synthesis or action: that is the questionRichard J Santen
Breast Cancer Research : BCR|January 9, 2009
Assessing individual risk for breast cancer: role of oestrogens and androgensRichard J Santen
Maturitas|October 21, 2019
"Re-booting" after retirement: Novel approach using telemedicine to solve the work-force gap in diabetes managementRichard J Santen
Endokrynologia Polska|October 18, 2007
The oestrogen paradox: a hypothesisRichard J Santen
The Journal of Steroid Biochemistry and Molecular Biology|July 23, 2013
Menopausal hormone therapy and breast cancerRichard J Santen
Steroids|September 6, 2003
Inhibition of aromatase: insights from recent studiesRichard J Santen
Women'S Health (London, England)|December 17, 2008
Does menopausal hormone therapy initiate new breast cancers or promote the growth of existing ones?Richard J Santen
Menopause (New York, N.Y.)|March 22, 2017
Use of cardiovascular age for assessing risks and benefits of menopausal hormone therapyRichard J Santen
Journal of Molecular Endocrinology|October 7, 2015
Celebrating 75 years of oestradiolEvan Simpson, Richard J Santen
Pageof 11